Evidence map›Paper›PMID 31040244›Full record

ArticlemBio2019

Reiterative Synthesis by the Ribosome and Recognition of the N-Terminal Formyl Group by Biosynthetic Machinery Contribute to Evolutionary Conservation of the Length of Antibiotic Microcin C Peptide Precursor.

Inna Zukher, Michael Pavlov, Darya Tsibulskaya, Alexey Kulikovsky, Tatyana Zyubko, Dmitry Bikmetov, Marina Serebryakova, Satish K Nair, Måns Ehrenberg, Svetlana Dubiley and 1 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Genome-resolved analysis of Serratia marcescens strain SMTT infers niche specialization as a hydrocarbon-degrader.DNA research : an international journal for rapid publication of reports on genes and genomes · 2024
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Microcins inFrontiers in microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Inna ZukherInstitute of Gene Biology, Russian Academy of Science, Moscow, Russia.
Michael PavlovUppsala Biomedicinska Centrum BMC, Uppsala, Sweden.
Darya TsibulskayaInstitute of Gene Biology, Russian Academy of Science, Moscow, Russia.
Alexey KulikovskyInstitute of Gene Biology, Russian Academy of Science, Moscow, Russia.
Tatyana ZyubkoCenter for Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.
Dmitry BikmetovCenter for Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.
Marina SerebryakovaInstitute of Gene Biology, Russian Academy of Science, Moscow, Russia.
Satish K NairUniversity of Illinois, Urbana, Illinois, USA.
Måns EhrenbergUppsala Biomedicinska Centrum BMC, Uppsala, Sweden.
Svetlana DubileyInstitute of Gene Biology, Russian Academy of Science, Moscow, Russia.
Konstantin SeverinovInstitute of Gene Biology, Russian Academy of Science, Moscow, Russia severik@waksman.rutgers.edu.
Skolkovo Institute of Science and Technology · RUInstitute of Gene Biology · RUInstitute of Molecular Genetics · RULomonosov Moscow State University · RURutgers, The State University of New Jersey · USUniversity of Illinois System · US

Funding

Exploring Peptide Conjugates as Trojan Horse Systems for Drug Design and DiscoveryR01AI117210 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NAIR, SATISH K · 2016 to 2020
$2.2M
NIAID NIH HHS R01 AI117210
6 · The paper itself

Abstract

Microcin C (McC) is a peptide adenylate antibiotic produced by

Indexed as

Protein BiosynthesisAnti-Bacterial AgentsBacteriocinsDNA Mutational AnalysisEscherichia coliN-FormylmethionineOpen Reading FramesPlasmidsRibosomesAnti-Bacterial AgentsBacteriocinsmicrocinN-Formylmethionineantibioticmicrocinribosometranslation initiation

Identifiers

PMID31040244
PMCPMC6495379
OpenAlexW2943639827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.